These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12116821)

  • 1. Regulation of endothelial function in coronary microcirculation by HMG-CoA reductase drugs.
    Di Napoli P; Taccardi AA; Di Gioacchino L; De Caterina R; Barsotti A
    Ital Heart J; 2002 Jun; 3 Suppl 4():20S-23S. PubMed ID: 12116821
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin improves diabetes-induced coronary endothelial dysfunction.
    Tawfik HE; El-Remessy AB; Matragoon S; Ma G; Caldwell RB; Caldwell RW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):386-95. PubMed ID: 16849625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP; Walter MF; Jacob RF
    Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive hyperemia as a test of endothelial or microvascular function?
    Minson CT; Wong BJ
    J Am Coll Cardiol; 2004 Jun; 43(11):2147; author reply 2147-8. PubMed ID: 15172427
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW; Lefer DJ
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidative effects of statins.
    Adam O; Laufs U
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates may retrieve endothelial function in vascular diseases similar to statins' effects.
    Ugur Ural A; Avcu F; Ozturk K
    Eur J Haematol; 2008 Jul; 81(1):77-8. PubMed ID: 18331595
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins and coronary microvascular dysfunction in patients with acute ST segment elevation myocardial infarction.
    Celik T; Demirkol S; Celik M; Yuksel UC; Iyisoy A
    Int J Cardiol; 2012 Mar; 155(3):480-1. PubMed ID: 22245479
    [No Abstract]   [Full Text] [Related]  

  • 12. Microcirculation as a target for the anti-inflammatory properties of statins.
    Scalia R; Stalker TJ
    Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.
    Alvarez de Sotomayor M; Vega S; Mingorance C; Marhuenda E; Herrera MD
    Pharmacology; 2008; 82(2):89-96. PubMed ID: 18509252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-mediated inhibition of Rho: only to get more NO?
    Brandes RP
    Circ Res; 2005 May; 96(9):927-9. PubMed ID: 15890979
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regulation of endothelial NO-synthase expression and vascular endothelium dysfunction in cardiovascular pathology].
    Kravchenko NA; Iarmysh NV
    Tsitol Genet; 2008; 42(4):69-81. PubMed ID: 19140434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent.
    Dhein S; Salameh A
    Circulation; 1999 Aug; 100(9):1011. PubMed ID: 10468534
    [No Abstract]   [Full Text] [Related]  

  • 17. The nonlipid effects of statins on endothelial function.
    Beckman JA; Creager MA
    Trends Cardiovasc Med; 2006 Jul; 16(5):156-62. PubMed ID: 16781949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins as coronary vasodilators in isolated bovine coronary arteries--involvement of PGI2 and NO.
    Lorkowska B; Chlopicki S
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):133-8. PubMed ID: 15626596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
    Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
    Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New findings on the action of HMG-CoA-reductase inhibitors].
    Laufs U; Böhm M; Liao JK
    Dtsch Med Wochenschr; 1997 Oct; 122(41):1255-9. PubMed ID: 9378055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.